Dev agency for API-driven startups.
Create flexible data endpoints, abstract the boring stuff & focus on buiding your app.
Next Gen Antibody Platform
Boreal is developing a new antibody discovery technology that involves breaking tolerance in vivo to generate broader antibody diversity against tough to immunize drug targets, like GPCRs and other transmembrane proteins.
Selectively purify nonfucosylated antibodies
Zepteon has developed a breakthrough antibody development and manufacturing technology that enables biopharmaceutical companies to evaluate and tune their drug potency. This is accomplished by separating high potency antibodies (nonfucosylated) from complex mixtures ...
Oncolinx is developing next-generation, targeted cancer therapeutics.
Oncolinx is developing the next generation of antibody-drug conjugates (ADCs)--powerful, targeted cancer therapies that are more effective and have dramatically fewer side effects than current methods of cancer treatment. These therapies can be targeted to nearly ...